Medicines Co
MDCO
MDCO was delisted on the 3rd of January, 2020.
166 hedge funds and large institutions have $1.9B invested in Medicines Co in 2014 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 57 increasing their positions, 50 reducing their positions, and 25 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
64% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 25
25% more capital invested
Capital invested by funds: $1.52B → $1.9B (+$382M)
14% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 50
9% more funds holding
Funds holding: 152 → 166 (+14)
51% less call options, than puts
Call options by funds: $6.41M | Put options by funds: $13M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
PointState Capital
New York
|
+$33.1M |
| 2 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$32.9M |
| 3 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$32.7M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$19.1M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$10.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$71.2M |
| 2 |
RA
Royce & Associates
New York
|
-$51.6M |
| 3 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$16.7M |
| 4 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$15.9M |
| 5 |
SPC
Slate Path Capital
New York
|
-$9.55M |
MDCO Hedge Fund Activity: Q4 2014 in Review
166 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Medicines Co (MDCO) for Q4 2014, worth a combined $1.9B — up 25% from $1.52B a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new MDCO positions and 25 closed out — a net gain of 16 holders — while 57 added to existing stakes and 50 trimmed.
The largest buyer was PointState Capital, adding an estimated $33.1M. The largest seller was Fidelity Investments, cutting an estimated $71.2M.
- 166 institutional investors held Medicines Co (MDCO) as of Q4 2014, up from 152 in Q3 2014.
- Funds reported $1.9B of Medicines Co stock for Q4 2014, up 25% quarter-over-quarter.
- 41 funds opened new Medicines Co positions in Q4 2014 and 25 closed out, a net change of +16 holders.
- The largest Medicines Co buyer in Q4 2014 was PointState Capital, an estimated $33.1M added.
- The largest Medicines Co seller in Q4 2014 was Fidelity Investments, an estimated $71.2M sold.
Based on aggregated 13F filings for Q4 2014.